The surgical perspective on early detection and prevention strategies

Surgery is not only a treatment for disease; it is also a vantage point for recognizing risk, detecting problems earlier, and preventing avoidable harm. From a surgical perspective, early detection means identifying a condition or complication while intervention is more likely to be effective and less invasive, while prevention means reducing the chance that disease, surgical complications, or delayed diagnosis will occur. Evidence from cancer screening, perioperative medicine, and surgical safety shows why prevention and timely assessment matter: the World Health Organization estimates that around one in six people worldwide develops cancer during their lifetime, and its surgical-safety guidance emphasizes standardized checks to reduce preventable harm. This article explains how surgeons contribute to prevention, how screening and risk assessment work, how perioperative strategies reduce complications, and how patients and health systems can act on the evidence.

Surgeons’ role in early detection and prevention

A surgical perspective on early detection and prevention is a clinical approach that combines risk recognition, diagnostic evaluation, timely referral, and interventions designed to prevent disease progression or treatment-related harm. The American College of Surgeons describes quality surgical care as extending across the continuum of care, from prevention and diagnosis through treatment and recovery. Surgeons therefore work alongside primary-care clinicians, radiologists, pathologists, anesthesiologists, and public-health teams rather than acting only at the operating table.

The approach has two linked aims: detect significant disease early enough to improve the balance of benefit and harm, and prevent avoidable illness or complications through evidence-based action. It includes population screening for selected conditions, evaluation of symptoms and abnormal findings, risk-reducing procedures for carefully selected patients, and safety practices before, during, and after surgery. Early detection is not synonymous with testing everyone for everything; screening is useful when evidence shows that its benefits outweigh false positives, overdiagnosis, and unnecessary procedures.

Risk assessment and timely diagnosis

Risk assessment identifies factors that change the probability of disease or complications, such as age, family history, smoking, medications, previous operations, and chronic conditions. Surgeons use this information to guide examination, imaging, biopsy, referral, and operative planning. For example, a new breast lump requires diagnostic assessment rather than routine screening alone, while an inherited cancer syndrome may justify specialist counseling and a personalized surveillance plan.

The distinction matters because screening is intended for people without symptoms, whereas diagnostic testing investigates symptoms or an abnormal screening result. The National Cancer Institute notes that screening tests can produce false-positive results and may detect abnormalities that would never have caused harm. Clinicians must therefore interpret findings in context and explain the next steps, including the possibility of repeat testing or biopsy.

Prevention across the surgical continuum

Prevention includes primary measures that reduce disease risk, secondary measures that find disease earlier, and perioperative measures that avert complications. Examples include tobacco cessation before an operation, appropriate cancer screening, vaccination where relevant, medication reconciliation, infection-prevention protocols, and early mobilization after surgery. The right intervention depends on a person’s risk, preferences, and likely absolute benefit.

This continuum leads naturally from identifying disease before it becomes advanced to reducing harm when an operation is needed. The two goals overlap: earlier diagnosis can make treatment less extensive, while thoughtful preparation can make necessary treatment safer.

Screening and early diagnosis in surgical practice

Screening is the systematic use of a test to identify a condition in people who do not yet have symptoms. The World Health Organization’s screening principles stress that a condition should be an important health problem, that an accepted treatment should be available, and that the test and follow-up pathway should be accessible and clinically effective. For surgeons, screening is most relevant when it can identify disease at a stage where treatment changes outcomes.

Cancer screening and risk-based surveillance

Cancer screening can identify selected cancers or precancerous changes before symptoms arise. In the United States, the National Cancer Institute reports that established screening programs include breast, cervical, colorectal, and lung cancer screening for eligible groups; recommendations differ by age, risk, and guideline. Colorectal screening is a clear example of prevention as well as detection: some tests find cancer, while colonoscopy can also identify and remove precancerous polyps.

The U.S. Preventive Services Task Force recommends colorectal cancer screening for average-risk adults aged 45 to 75, with individualized decisions for adults aged 76 to 85. This age range reflects evidence that screening can reduce colorectal cancer deaths while acknowledging that the balance of benefit and burden changes with age and health. People with a strong family history, inflammatory bowel disease, or a known hereditary syndrome may need a different plan and should discuss it with a qualified clinician.

Risk-based surveillance is distinct from population screening. It uses personal or inherited risk to tailor the timing and type of testing. For example, the National Cancer Institute identifies pathogenic variants in genes such as BRCA1 and BRCA2 as factors associated with increased breast and ovarian cancer risk. Genetic counseling can help patients understand testing and consider surveillance or risk-reducing options; surgery is not automatic and decisions should be individualized.

Symptom recognition, diagnostic pathways, and delays

Early diagnosis begins when symptoms are recognized, assessed promptly, and followed through to a confirmed diagnosis. A surgeon may become involved after imaging or biopsy identifies a suspicious lesion, but the pathway often begins in primary care or an emergency department. Clear referral criteria, timely diagnostic imaging, pathology review, and communication of results help prevent patients from being lost between services.

Early diagnosis should not be confused with indiscriminate testing. A test is valuable when it leads to an appropriate action and improves outcomes, not simply because it detects more abnormalities. Clinicians should explain uncertainty and ensure that a positive result triggers a reliable follow-up plan. Patients can help by reporting persistent or worsening symptoms, sharing relevant family history, and asking who will communicate test results and arrange follow-up.

Perioperative prevention and surgical safety

Perioperative prevention refers to measures taken before, during, and after an operation to reduce complications and support recovery. The World Health Organization’s Surgical Safety Checklist is a standardized team tool that confirms key information at critical points, including patient identity, procedure and site, anesthesia concerns, antibiotic timing, and plans for recovery. The WHO introduced the checklist as part of its Safe Surgery Saves Lives initiative.

Preoperative optimization

Preoperative optimization identifies and improves modifiable health risks before surgery. It may include reviewing heart and lung disease, diabetes, nutrition, anemia, medications, smoking, alcohol use, and mobility. The aim is not to delay every operation until all risks disappear; rather, the team weighs the urgency of surgery against the likely benefit of preparation.

Smoking cessation is a practical example. The American College of Surgeons advises that stopping smoking before surgery can improve healing and reduce respiratory and wound complications; the length of time needed varies, and patients should seek support rather than assume that stopping shortly before an operation is pointless. Medication review is equally important because anticoagulants, diabetes medicines, and some supplements can affect bleeding, glucose control, or anesthesia planning.

Infection prevention and checklist-based care

Surgical-site infection prevention combines measures such as appropriate antibiotic prophylaxis, skin preparation, sterile technique, temperature and glucose management where indicated, and clear postoperative wound-care instructions. The Centers for Disease Control and Prevention’s guideline for prevention of surgical-site infections emphasizes evidence-based practices selected according to procedure and patient circumstances. Antibiotics are not a substitute for sterile technique and should be used appropriately to reduce both infection risk and unnecessary antimicrobial exposure.

The WHO Surgical Safety Checklist provides a real-world example of a systems intervention. In a multicenter study published in the New England Journal of Medicine, implementation across eight hospitals was associated with a decline in major inpatient complications from 11.0% to 7.0% and in deaths from 1.5% to 0.8%. These results demonstrate the potential value of coordinated safety processes, though outcomes depend on local implementation, teamwork, and the quality of the broader care system.

Recovery, follow-up, and learning from complications

Postoperative prevention continues after discharge. Wound monitoring, pain control, nutrition, mobility, prevention of blood clots when indicated, and clear instructions about warning signs can reduce avoidable deterioration. Patients should know whom to contact for fever, increasing redness or drainage, worsening pain, breathing difficulty, or other symptoms specified by their care team.

Quality improvement uses complication data and patient feedback to identify patterns and strengthen care. The American College of Surgeons’ National Surgical Quality Improvement Program (ACS NSQIP) collects risk-adjusted outcomes to help participating hospitals compare performance and target improvement. Such data support learning at the system level; they should be interpreted in context and are not a substitute for individualized clinical judgment.

Balancing benefits, harms, and equitable access

Early detection and prevention are effective only when the likely benefit is meaningful and care is accessible. Screening can cause anxiety, false alarms, invasive follow-up, and overdiagnosis; surgery itself carries risks such as bleeding, infection, and anesthesia complications. Shared decision-making helps align choices with a patient’s risk profile, values, and the best available evidence.

Access also shapes outcomes. The World Health Organization estimates that approximately 5 billion people lack access to safe and affordable surgical and anesthesia care when needed. Barriers to screening, diagnostic imaging, specialist referral, and timely surgery can therefore undermine prevention even when effective tests or treatments exist. Health systems can respond through organized screening pathways, patient navigation, accessible communication, and investment in trained teams and essential surgical services.

A useful way to present outcomes is a comparison chart showing screening eligibility, expected benefit, possible harms, and recommended follow-up for each condition. Such a chart should be based on current national guidance and updated as recommendations change; it should not replace a clinician’s assessment.

Conclusion: making early detection and prevention part of surgical care

The surgical perspective on early detection and prevention connects risk assessment and diagnosis with screening, preoperative optimization, infection control, checklist-based teamwork, and recovery planning. The evidence supports targeted screening and reliable follow-up rather than testing without a clear purpose. It also shows that coordinated safety practices can reduce complications and that access to timely surgical care remains a major global challenge.

Patients can review age- and risk-appropriate screening with a health professional, share family and medical history, seek assessment for persistent symptoms, and follow pre- and postoperative instructions. Clinicians and health systems can strengthen referral pathways, use evidence-based checklists, monitor outcomes, and address barriers to care. These steps make prevention and early detection practical components of safer, more effective surgery.

Sources: World Health Organization, Cancer, https://www.who.int/news-room/fact-sheets/detail/cancer; World Health Organization, WHO Guidelines for Safe Surgery 2009: Safe Surgery Saves Lives, https://www.who.int/publications/i/item/9789241598552; Haynes, A. B., et al., A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population, New England Journal of Medicine, 2009, https://www.nejm.org/doi/full/10.1056/NEJMsa0810119; U.S. Preventive Services Task Force, Colorectal Cancer: Screening, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening; National Cancer Institute, Cancer Screening Overview, https://www.cancer.gov/about-cancer/screening/patient-screening-overview; National Cancer Institute, BRCA Gene Changes: Cancer Risk and Genetic Testing, https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet; Centers for Disease Control and Prevention, Guideline for the Prevention of Surgical Site Infection, 2017, https://www.cdc.gov/infection-control/hcp/surgical-site-infection/index.html; American College of Surgeons, Smoking and Surgery, https://www.facs.org/for-patients/preparing-for-surgery/smoking/; American College of Surgeons, National Surgical Quality Improvement Program, https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/; World Health Organization, Global Surgery, https://www.who.int/health-topics/integrated-people-centred-care#tab=tab_1.